Jim On S - Search Results

1

Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial.

Guttman-Yassky E, Brunner PM, Neumann AU, Khattri S, Pavel AB, Malik K, Singer GK, Baum D, Gilleaudeau P, Sullivan-Whalen M, Rose S, Jim On S, Li X, Fuentes-Duculan J, Estrada Y, Garcet S, Traidl-Hoffmann C, Krueger JG, Lebwohl MG. Guttman-Yassky E, et al. Among authors: jim on s. J Am Acad Dermatol. 2018 May;78(5):872-881.e6. doi: 10.1016/j.jaad.2018.01.016. Epub 2018 Jan 17. J Am Acad Dermatol. 2018. PMID: 29353025 Free PMC article. Clinical Trial.

2

Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.

Brunner PM, Pavel AB, Khattri S, Leonard A, Malik K, Rose S, Jim On S, Vekaria AS, Traidl-Hoffmann C, Singer GK, Baum D, Gilleaudeau P, Sullivan-Whalen M, Fuentes-Duculan J, Li X, Zheng X, Estrada Y, Garcet S, Wen HC, Gonzalez J, Coats I, Cueto I, Neumann AU, Lebwohl MG, Krueger JG, Guttman-Yassky E. Brunner PM, et al. Among authors: jim on s. J Allergy Clin Immunol. 2019 Jan;143(1):142-154. doi: 10.1016/j.jaci.2018.07.028. Epub 2018 Aug 17. J Allergy Clin Immunol. 2019. PMID: 30121291 Clinical Trial.

3

Relationship between severity of the local skin reactions and the rate of local skin reaction resolution in patients treated with ingenol mebutate gel.

Jim On SC, Knudsen KM, Skov T, Lebwohl M. Jim On SC, et al. Clin Cosmet Investig Dermatol. 2016 Aug 24;9:211-6. doi: 10.2147/CCID.S113044. eCollection 2016. Clin Cosmet Investig Dermatol. 2016. PMID: 27601928 Free PMC article.

4

Evaluating the Efficacy of Photodynamic Therapy with 20% Aminolevulinic Acid and Microdermabrasion as a Combination Treatment Regimen for Acne Scarring: A Split-face, Randomized, Double-blind Pilot Study.

Linkner RV, Jim On S, Haddican M, Singer G, Shim-Chang H. Linkner RV, et al. Among authors: jim on s. J Clin Aesthet Dermatol. 2014 May;7(5):32-5. J Clin Aesthet Dermatol. 2014. PMID: 24847407 Free PMC article.

5

Reduced degree of irritation during a second cycle of ingenol mebutate gel 0.015% for the treatment of actinic keratosis.

Jim On SC, Haddican M, Yaroshinsky A, Singer G, Lebwohl M. Jim On SC, et al. Cutis. 2015 Jan;95(1):47-51. Cutis. 2015. PMID: 25671445

6

Regression Analysis of Local Skin Reactions to Predict Clearance of Actinic Keratosis on the Face in Patients Treated With Ingenol Mebutate Gel: Experience from Randomized Controlled Trials.

Jim On S, Knudsen KM, Skov T, Lebwohl M. Jim On S, et al. J Drugs Dermatol. 2017 Feb 1;16(2):112-114. J Drugs Dermatol. 2017. PMID: 28300852

7

Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face.

Jim On SC, Hashim PW, Nia JK, Lebwohl MG. Jim On SC, et al. J Drugs Dermatol. 2017 May 1;16(5):432-436. J Drugs Dermatol. 2017. PMID: 28628678

8

Extramammary Paget disease: failure to respond to topical imiquimod 5%.

Jim On SC, Izumi AK. Jim On SC, et al. J Am Acad Dermatol. 2011 Sep;65(3):656-657. doi: 10.1016/j.jaad.2010.04.035. J Am Acad Dermatol. 2011. PMID: 21839324 No abstract available.

9

Disseminated superficial actinic porokeratosis treated with ingenol mebutate gel 0.05.

Anderson I, Routt ET, Jim On SC. Anderson I, et al. Among authors: jim on sc. Cutis. 2017 Mar;99(3):E36-E39. Cutis. 2017. PMID: 28398427

10

A longstanding deep-seated nuchal tumor.

Ibrahimi OA, Jim On SC, Fung MA, Eisen DB. Ibrahimi OA, et al. Int J Dermatol. 2012 Aug;51(8):910-2. doi: 10.1111/j.1365-4632.2011.05364.x. Int J Dermatol. 2012. PMID: 22788805 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page